Excepting the year's previous quarter, fourth-quarter spending on medical device injury claim ads decreased, totaling over $966,000 for approximately 6,000 ads nationwide. Notably, spinal cord stimulators emerged as a new mass tort ad target, with 111 ads aired.
Excepting the year’s first quarter, third quarter spending exceeded all prior quarters since the second quarter of 2023. Estimated spending on these ads jumped by over $280,000 or 25%.